Industry Analysis on Botulinum Neurotoxins Report

​Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders is a new market research publication announced by Reportstack. This report is based on the identification, description and assessment of all relevant stakeholders in the field of botulinum neurotoxins. The report analyzes the existing product portfolios in regulated and less regulated markets, commercial information, and measures to maintain sales and market shares by upside indications and life cycle management measures. The report addresses the new wave of botulinum neurotoxin product candidates in development, such as biosimilars and biosuperior botulinum neurotoxins.

Special emphasis is put in the report on improvements by pharmaceutical technologies, such as liquid protein formulations and transdermal drug delivery technologies. The significance of recombinant DNA technology is discussed regarding botulinum neurotoxin engineering, modification and manufacturing. Chances and challenges for the stakeholders in the botulinum neurotoxin market are evaluated.

The market for botulinum neurotoxin products has significantly grown over the last years, due to new medical indications developed and due to more cosmetic procedures performed with botulinum neurotoxins in ageing societies in which physical appearance is highly valued. Although the botulinum neurotoxin market commercially is dominated by only one company, existing competitors, new players and technologies are setting the ground for biosuperiors as well as for biosimilars. As biosimilar botulinum toxins will put the price of first generation products under pressure, only innovation can justify higher prices.

Benefits from the report:

Identify established and emerging players in the field;Find out which enabling technologies are attractive for the next generation;Understanding the driving forces for the future of the botulinum neurotoxin market;Learn the key success factors in marketing new botulinum neurotoxin products;Recognize the challenges acting on established stakeholders;Learn which technologies and product candidates are attractive for partnering;